When Nanotechnology Meets Lipids: The Rise of Nanocochleates

In the science of drug discovery, we have seen two breakthroughs: one being nanotechnology, where nanodrug particles with better drug availability help us deliver medicines more effectively, and the other being lipid-based drug molecules, which show better bioavailability, absorption, and efficacy.

And what if both these technologies are combined? Yes, that has already been done and these molecules are called nanocochleates.
Nanocochleates are cylindrical, cigar-shaped structures made from negatively charged lipids and divalent cations (like calcium). Their unique rolled lipid bilayer structure allows them to encapsulate both hydrophilic and hydrophobic drugs, protecting them from harsh gastrointestinal conditions and improving drug stability and bioavailability.

What is new!?

  • Enhance the oral bioavailability of poorly soluble drugs

  • Protect sensitive molecules like proteins, peptides, genes, and vaccines

  • Provide controlled and sustained drug release

  • Reduce toxicity and side effects

  • Offer excellent stability, even after lyophilization

Applications

  • Cancer therapy (e.g., paclitaxel, doxorubicin)

  • Diabetes management (e.g., insulin, resveratrol)

  • Antifungal and antiviral treatment (e.g., amphotericin B, nelfinavir)

  • Vaccines, gene delivery, and nutraceuticals

With the above description, we can definitely say that nanocochleates will be a great revolution.

What are your thoughts?? Will nanocochleates be a revolution or get lost among the many already present?
Have you ever seen them being used in clinical practice?

MBH/PS

3 Likes

it will stay after some good years first to rich people then to middle class

1 Like

Yes that is True!

Nicely explained

1 Like

This article touches on a fascinating area of nanomedicine — nanocochleates show how lipid-based nanotechnology can transform drug delivery. Their spiral multilayer structure allows them to encapsulate and protect diverse molecules while improving stability, bioavailability, and targeted release, which could overcome limitations seen with conventional carriers. These systems have potential across pharmaceuticals and nutraceuticals, from enhancing oral absorption of poorly soluble drugs to supporting vaccine or gene delivery platforms. Exploring innovations like this highlights how formulation science continues to reshape therapeutic effectiveness and patient outcomes.

1 Like